BridgeMD
Testosterone Replacement Therapy in Women with Turner Syndrome
EU CTIS ID: 2024-517755-12-00
What this study is testing
The objective of this study is to evaluate the endocrine, physiological, cardiovascular neurocognitive, and genomic effects of transdermal TRT, as a supplement to ERT, in women with TS.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Turner Syndrome (all karyotypes)
- Age between 18 and 50 years (both included)
- Receiving estrogen replacement therapy
- Speaking Danish
You likely can't join if
- Former or present untreated or uncontrolled chronic disease
- Diagnosed breast, cervical or endometrial cancer
- Grave obesity (BMI > 40)
- Heavy smoking (> 20 cigarettes/day)
- Allergy to the drug used
- Levels of androgen above normative levels
See the full eligibility criteria
- Turner Syndrome (all karyotypes)
- Age between 18 and 50 years (both included)
- Receiving estrogen replacement therapy
- Speaking Danish
- Former or present untreated or uncontrolled chronic disease
- Diagnosed breast, cervical or endometrial cancer
- Grave obesity (BMI > 40)
- Heavy smoking (> 20 cigarettes/day)
- Allergy to the drug used
- Levels of androgen above normative levels
- Pregnancy and lactation
- Previous stroke, acute myocardial infarction or venous thromboembolism
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.